Kiniksa Pharmaceuticals International, plc
- Stock
- Ticker KNSA
- Nasdaq
Performance, volatility and drawdowns of Kiniksa Pharmaceuticals International, plc since 05/2018, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $90,371. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −83.1% in 10/2019, measured from the peak in 09/2018. It took 82 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 123 | 138 | 157 | 181 | 202 | 214 | 244 | 286 |
| Gross profit | 105 | 120 | 138 | 161 | 181 | 193 | 220 | 258 |
| Operating income | -19 | 13 | 20 | 24 | 20 | 29 | 27 | 54 |
| EBITDA | -19 | 14 | 20 | 24 | 20 | 30 | 27 | 54 |
| Net income | -8.9 | 8.5 | 18 | 18 | 14 | 23 | 25 | 47 |
| Earnings per share | -0.12 | 0.11 | 0.23 | 0.23 | 0.18 | 0.27 | 0.30 | 0.56 |
| Balance sheet | ||||||||
| Total assets | 581 | 599 | 661 | 712 | 764 | 825 | 896 | 983 |
| Liabilities | 142 | 142 | 166 | 177 | 196 | 220 | 242 | 273 |
| Equity | 438 | 457 | 495 | 535 | 568 | 606 | 654 | 710 |
| Cash | 184 | 157 | 192 | 175 | 166 | 190 | 176 | 82 |
| Cash flow | ||||||||
| Operating cash flow | 19 | 22 | 28 | 34 | 54 | 50 | 47 | 48 |
| Capital expenditure | -0.2 | -0.1 | -0.2 | -0.7 | -0.6 | -0.2 | -0.7 | -0.2 |
| Free cash flow | 19 | 22 | 28 | 33 | 53 | 50 | 47 | 47 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2025 at +108.5%, weakest 2019 at −60.6%. 5 of 7 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 27 Oct 2026 | $0.56 |
| 28 Jul 2026 | $0.30 |
| 28 Apr 2026 | $0.27 |
| 24 Feb 2026 | $0.18 |
| 28 Oct 2025 | $0.23 |
| 29 Jul 2025 | $0.23 |
| 29 Apr 2025 | $0.11 |
| 25 Feb 2025 | −$0.12 |
| 29 Oct 2024 | −$0.18 |
| 25 Jul 2024 | −$0.06 |
| 25 Apr 2024 | −$0.25 |
| 28 Feb 2024 | $0.36 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €7.2bn
- Market cap in trading currency
- $7.97bn
- Enterprise value
- $7.40bn
- P/E
- 71.7
- P/S
- 8.43
- P/B
- 11.23
- EV/Sales
- 7.83
- EV/EBITDA
- 56.2
- Earnings yield
- 1.4%
- FCF yield
- 2.5%
Results (last four quarters)
- Revenue
- $946m
- Gross profit
- $853m
- EBITDA
- $132m
- Net income
- $110m
- Earnings per share
- $1.31
- Revenue per share
- $11.14
- Revenue growth
- +58.1%
- Earnings growth
- +156.8%
Profitability
- Gross margin
- 90.2%
- Operating margin
- 13.8%
- Net margin
- 11.6%
- Return on equity
- 17.6%
- Return on assets
- 11.1%
Balance sheet and cash flow
- Cash
- $569m
- Cash per share
- $6.70
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 3.91
- Book value per share
- $8.36
- Operating cash flow
- $199m
- Free cash flow
- $197m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 84.9m
- Volume
- 544,863
- Avg. volume 3 months
- 673,868
- Relative volume
- 0.8
Price and technicals
- Price
- $93.90
- 1 day
- +0.4%
- 52-week high
- $98.76
- 52-week low
- $37.92
- Distance to 52-week high
- −4.9%
- Distance to 52-week low
- +147.6%
- Distance to 50-day line
- +11.9%
- Distance to 200-day line
- +46.5%
- RSI (14)
- 56
- Volatility 1M
- 93.9%
Performance
- 1 week
- −2.5%
- 1 month
- +16.2%
- 3 months
- +18.3%
- 6 months
- +76.4%
- YTD
- +127.6%
- 1 year
- +122.7%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has KNSA performed since 05/2018?
$10,000 grew to $48,225 by 20 Nov 2026, which is +20.4% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is KNSA?
Volatility was 59.3% per year, measured on monthly returns. The largest decline from a peak was −83.1%, with the low in 10/2019.
How does KNSA compare with a broad equity ETF?
Over the same period Global equities (VT) returned +10.0% per year at 16.1% volatility, KNSA returned +20.4% at 59.3%. The correlation of monthly returns was 0.03; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.